News history January 06, 2024

Day1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31
MonthsJanuary | February | March | April | May | June |
Year2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Filters

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Use your lists to filter news history by 2024-01-06 .

Watchlists
To use this feature you must be a member
Log in Sign up

Most Read News

Saudi Arabia cuts Feb Arab Light crude price to Asia to 27-month low

January 07, 2024 at 05:51 am EST RE

Veratin Limited Partner with vegetablesWA

January 07, 2024 at 05:29 pm EST AW

All the latest stock market news at 2024-01-06 .

148 news
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on SelfWealth Limited's Equity Buyback Plan announced on October 4, 2023.
05:55:00 2024-01-07 pm EST
Connexion Mobility Ltd Announces Executive Changes
05:55:00 2024-01-07 pm EST
Ascendis Pharma A/S Introduces Vision 2030
05:45:00 2024-01-07 pm EST
CosmoSteel Holdings Limited Proposes Final One-Tier Tax Exempt Dividend for the Year Ended 30 September 2023, Payable on 16 February 2024
05:44:00 2024-01-07 pm EST
Veratin Limited Partner with vegetablesWA
05:29:00 2024-01-07 pm EST
IShares S&P/ASX 20 ETF Revises Estimated Distribution, Payable on 18 January 2024
05:17:00 2024-01-07 pm EST
Cann Group Limited Announces Chief Financial Officer Changes, Commencing on 8 April 2024
05:13:00 2024-01-07 pm EST
Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs
05:13:00 2024-01-07 pm EST
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
05:01:03 2024-01-07 pm EST
Heron Therapeutics, Inc. Enters into Five-Year Distributor Partnership with Crosslink Life Sciences, LLC to Expand the Sales Network Supporting ZYNRELEF
05:00:00 2024-01-07 pm EST
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
05:00:00 2024-01-07 pm EST
Silk Logistics Holdings Limited Appoints James Nicholias as New Chief Financial Officer
04:54:00 2024-01-07 pm EST
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Chief Financial Officer in 2024
04:30:00 2024-01-07 pm EST
Exact Sciences Corporation Provides Revenue Guidance for the Year Ended December 31, 2023 and 2024
04:30:00 2024-01-07 pm EST
Exact Sciences Corporation Announces Jeff Elliott Plans to Step Down as Executive Vice President
04:30:00 2024-01-07 pm EST
Microbiome Health Company Biome Australia Limited Revises Earnings Guidance for 2024
04:27:00 2024-01-07 pm EST
Metcash Limited Appoints Kylie Wallbridge as CEO of the Liquor Pillar
04:26:00 2024-01-07 pm EST
Adriatic Metals PLC Appoints Alex Budden as Chief Sustainability Officer
04:24:00 2024-01-07 pm EST
Silver Lake Resources Limited Announces Preliminary Sales Results for Quarter Ended December 2023
04:23:00 2024-01-07 pm EST
Belararox Limited Appoints Steve Garwin as Chief Technical Advisor
04:23:00 2024-01-07 pm EST
Red 5 Limited Provides Production Guidance for the Fiscal Year 2024
04:22:00 2024-01-07 pm EST
Red 5 Limited Reports Sales Results for the Quarter Ended December 2023
04:22:00 2024-01-07 pm EST
Red 5 Limited Reports Production Results for the Quarter and First Half Ended December 2023
04:22:00 2024-01-07 pm EST
Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024
04:01:01 2024-01-07 pm EST
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
04:01:01 2024-01-07 pm EST
Amicus Therapeutics, Inc. Announces Unaudited Preliminary Revenue Results for the Fourth Quarter and Full Year of 2023
04:00:00 2024-01-07 pm EST
Exelixis, Inc. Provides Earnings Guidance for Fiscal Year 2024
04:00:00 2024-01-07 pm EST
Exelixis, Inc. Announces Board Changes
04:00:00 2024-01-07 pm EST
Amicus Therapeutics, Inc. Provides Revenue Guidance for the Year 2024
04:00:00 2024-01-07 pm EST
Hologic, Inc. Provides Revenue Guidance for the First Quarter of 2024
04:00:00 2024-01-07 pm EST
ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MDRX
03:31:03 2024-01-07 pm EST
ROSEN, A LEADING AND RANKED FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
03:01:03 2024-01-07 pm EST
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
03:01:01 2024-01-07 pm EST
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
03:01:01 2024-01-07 pm EST
NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager
03:00:00 2024-01-07 pm EST
Vincerx Pharma, Inc. Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
03:00:00 2024-01-07 pm EST
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Microvast Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MVST, MVSTW
02:16:03 2024-01-07 pm EST
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries
02:01:04 2024-01-07 pm EST
Specialised Therapeutics Signs Exclusive Agreement with Ascendis Pharma A/S for Distribution and Commercialisation of Three Endocrinology Therapies in Australia and Select South-East Asia Countries
02:00:00 2024-01-07 pm EST
FAA: 171 Boeing MAX 9 airplanes to remain grounded until assured safe
01:58:35 2024-01-07 pm EST
FEDERAL AVIATION ADMINISTRATION SAYS 171 BOEING 737 MAX 9 AIRPLA…
01:58:35 2024-01-07 pm EST
SMG European Recovery SPAC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
01:09:01 2024-01-07 pm EST
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
01:04:01 2024-01-07 pm EST
UNION CALLS FOR GERMAN RAIL STRIKE JAN 10-12…
12:53:20 2024-01-07 pm EST
Acer Incorporated Expands SpatialLabs Stereoscopic 3D Portfolio with New Laptop and Gaming Monitor
12:10:00 2024-01-07 pm EST
Isomorphic Labs Announces Strategic Multi-Target Research Collaboration with Novartis
12:10:00 2024-01-07 pm EST
SCYX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
12:05:01 2024-01-07 pm EST
Acer Incorporated Unveils New Swift Go AI PCs with Intel Core Ultra Processors
12:00:00 2024-01-07 pm EST
Exagen Inc. Reaffirms Earnings Guidance for the Full Year Ended December 31, 2023
12:00:00 2024-01-07 pm EST
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
12:00:00 2024-01-07 pm EST
PAYC DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action Commenced by the Firm - PAYC
11:35:02 2024-01-07 am EST
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ON
11:35:02 2024-01-07 am EST
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Roblox Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RBLX
11:05:01 2024-01-07 am EST
Ultragenyx Pharmaceutical Inc. Reports Unaudited Preliminary Sales Results for 2023
11:00:00 2024-01-07 am EST
Ultragenyx Pharmaceutical Inc. Provides Revenue Guidance for 2024
11:00:00 2024-01-07 am EST
Calliditas Therapeutics Announces Executive Changes
11:00:00 2024-01-07 am EST
Caribou Biosciences, Inc. Appoints Tim Kelly as Chief Technology Officer
11:00:00 2024-01-07 am EST
Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones
11:00:00 2024-01-07 am EST
Special Edition : The Outlook for 2024
10:37:00 2024-01-07 am EST
IMF's executive board to approve Kenya's $938 mln deal on Jan. 17
10:29:08 2024-01-07 am EST
RxSightinc. Provides Earnings Guidance for Preliminary Unaudited Fourth Quarter 2023 , Preliminary Unaudited Fiscal Year 2023 and for Full-Year 2024
10:00:00 2024-01-07 am EST
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
10:00:00 2024-01-07 am EST
ONGC Limited Announces Commencement of First Oil Production from the Deep-Water KG-DWN-98/2 Block
09:48:00 2024-01-07 am EST
Q Holding Announces CEO Changes
09:46:00 2024-01-07 am EST
Q Holding Announces Management Changes
09:46:00 2024-01-07 am EST
Helios Klinikum Uelzen plans prayer service after fire with five fatalities
09:31:05 2024-01-07 am EST
IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance
09:01:04 2024-01-07 am EST
TV ratings: 'Ein starkes Team' strong leader
08:45:05 2024-01-07 am EST
New dimming rules for power grids - control boxes still under development
08:20:23 2024-01-07 am EST
IG Metall expects tough collective bargaining round at Volkswagen
08:20:06 2024-01-07 am EST
Akoya Biosciences Deploys the Maxfuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory At Stanford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform
08:00:00 2024-01-07 am EST
Akoya Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023 and for the Fiscal Year 2024
08:00:00 2024-01-07 am EST
Akoya Biosciences, Inc. and Thermo Fisher Scientific, Inc. Announce License and Distribution Agreement to Deliver Spatial Multiomics Workflow
08:00:00 2024-01-07 am EST
Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
08:00:00 2024-01-07 am EST
Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
08:00:00 2024-01-07 am EST
No results for this search
12